Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
m. sylvestris (1 trial)
Andrographis paniculata (2 trials)
fang(30) (1 trial)
Arthritis (Phase 2)
Arthritis, Rheumatoid (Phase 2)
Multiple Sclerosis (Phase 2)
Multiple Sclerosis, Chronic Progressive (Phase 2)
Multiple Sclerosis, Relapsing-Remitting (Phase 2)
Sclerosis (Phase 2)
Trials (4 total)
Trial APIs (3 total)